Oxurion NV【0G99】銘柄情報

Oxurion NV (0G99) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

4.88

( - )

買値

4.71

売値

5.11

出来高

0.00

0.00 日の範囲 0.00

4.88 52 週間の範囲 4.88

時価総額

432.814M

前日終値

4.88

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

811,033 €

発行済株式数

88,691,312

配当利回り

PER

-0.02

1 株当たり利益 (EPS)

-0.13

歳入

555k

純利益

-3.73M

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration. The company was formerly known as ThromboGenics NV and ch... Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. 詳細を表示

セクター

業界

ウェブサイト

www.oxurion.com

本社

Leuven, Belgium

設立

1991

Oxurion NV is listed in the sector of the ロンドン証券取引所 with ticker 0G99. The last closing price for Oxurion NV was 4.88 €. Over the last year, Oxurion NV shares have traded in a share price range of 4.88 € to 4.88 €.

Oxurion NV currently has 88,691,312 shares in issue. The market capitalisation of Oxurion NV is 432.81 € million. Oxurion NV has a price to earnings ratio (PE ratio) of -0.02.

Oxurion Share Consolidation

Oxurion Share Consolidation Oxurion Share Consolidation Leuven, BELGIUM – July 25, 2024 – 06:00 PM CET Oxurion NV (Euronext Brussels: OXUR) (the...

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Oxurion Announces Results on the Extraordinary General...

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Information on the Total Number of Voting...

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion Receives Transparency Notification from Atlas Special...

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 Oxurion provides...

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production...

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024 Oxurion...

期間 †	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	4.88	4.88	4.88	339	4.88	DE
52	4.88	4.88	4.88	262	4.88	DE
156	4.88	48800	4.88	112920	5.41021634	DE
260	4.88	48800	4.88	87886	5.27545188	DE